ClinicalTrials.Veeva

Menu

Upper Gastrointestinal Perforations: a Nationwide Registry-based Study

R

Region Stockholm

Status

Not yet enrolling

Conditions

Acute Abdomen

Treatments

Procedure: Surgical treatment type

Study type

Observational

Funder types

Other

Identifiers

NCT06154603
K 2023-7938

Details and patient eligibility

About

The primary aim of this project is to increase the knowledge about how perforations in the esophagus, stomach and small intestine are treated on a national level. Furthermore, secondary aims include assessment of how different treatment options and type of treating facilities relate to patient survival. This will be done by studying information about all adult patients with an upper GI perforation treated in Sweden during 2005-2023.

Enrollment

2,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age of at least 18 years
  • perforation in either oesophagus, stomach or small intestine
  • treatment carried out in Sweden
  • diagnosis set between January 2005 and August 2023

Exclusion criteria

  • children

Trial design

2,000 participants in 3 patient groups

Oesophageal perforation
Description:
Adult patients (at least 18 years of age) with an oesophageal perforation, treated for it at a Swedish hospital between 2005-2023.
Treatment:
Procedure: Surgical treatment type
Gastric perforation
Description:
Adult patients (at least 18 years of age) with a gastric perforation, treated for it at a Swedish hospital between 2005-2023.
Treatment:
Procedure: Surgical treatment type
Small intestinal perforation
Description:
Adult patients (at least 18 years of age) with a small intestinal perforation, treated for it at a Swedish hospital between 2005-2023.
Treatment:
Procedure: Surgical treatment type

Trial contacts and locations

1

Loading...

Central trial contact

Rebecka Ahl Hulme, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems